Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment > Tumor Necrosis Factor Inhibitors > Co.: BE. U (MAb/Phase III/Patents) > Patent
Patent's subsections
Assignee, Claims, No., Etc.
Total No. of U.S. Patents: 1
UpDate: 11.07.06
US Expiration Date: 06.06.2021
Patent's products
This section has no products